摘要
甲状腺髓样癌(MTC)是中等恶性程度的内分泌肿瘤,其恶性程度高于甲状腺乳头状腺癌(PTC)和甲状腺滤泡状腺癌(FTC),但发病率低于二者。本病例提示我们如有双侧甲状腺肿物的患者需要询问其家族史,注意有无遗传性MTC情况。
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2007年第5期292-293,共2页
Chinese Journal of Clinical Oncology
参考文献10
-
1Ball DW, Baylin SB, de Bustros AC. Medullary thyroid carcinoma. In: Braverman LE, Utiger RD, eds. Werner's and Ingbar's the Thyroid: A Fundamental and Clinical Text [M]. 7th edition. Philadelphia: Lippincott Raven Publishers, 1996. 946-960.
-
2Brandi ML, Gagel RF. Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2 [J]. J Clin Endocrinol Metab, 2001, 86(12): 5658-5671.
-
3郑敏,李春艳,成小松.RET原癌基因与遗传性甲状腺髓样癌关系的研究进展[J].国外医学(遗传学分册),2002,25(1):43-47. 被引量:10
-
4Fleming J, LeeJE, Bouvet M, et al. Surgical strategy for the treat ment of medullary thyroid carcinoma [j]. Ann Surg, 1999, 230(5): 697-707.
-
5Niccoli-Sire P, Murat A,Rohmer V, et al. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotypegenotype relationship in a large series of patients [j]. J Clin Endocrinol Metab, 2001, 86(8): 3746-3753.
-
6Hcshmafi HM, Gharib H, van Hccrdcn JA, ct al. Advances and controversies in the diagnosis and management of medullary thyroid carcinoma[j]. Am J Med, 1997. 103(1): 60-69.
-
7Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients[j]. Medicine (Baltimore), 1984, 63(6): 319-342.
-
8Kebebew E, Ituarte PH, Siperstein AE, et al. Medullary thyroid carcinoma: clinical characteristics, treatment prognostic factors, and a comparison of staging systems [j], Cancer, 2000, 88 (5): 1139-1148.
-
9Hyer SL, Vini L, A, Hem R, et al. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival [j]. EurJ Surg Oncol, 2000, 26(7): 686-690.
-
10Moley JF, Dilly WG, DeBenedetd MK. Improved results of cervical reoperafion for medullary thyroid carcinoma [j]. Ann Surg, 1997, 225(6): 734-740.
二级参考文献29
-
1Takalhashi M et al. Cell, 1985,42: 581-588.
-
2Pasini B et al. Oncogene, 1995,11: 1737-1743.
-
3Frank-RaueKetal.德国医学,1999,16:51-53.
-
4Dubeck P et al. Nature, 1996, 381: 789-793.
-
5Hazard JB et al. J Clin Endocrinol Metab,1959,19:152-161.
-
6Simpon NE et al. Nature, 1987, 328: 528-530.
-
7Muligan LM et al. Nature,1993, 363: 458-460.
-
8Donis-Keller H et al. Hum Mol Genet,1993,2: 851-856.
-
9Klein I et al. J Endocrinol, 2001, 170:661-666.
-
10Lairmore TC et al. Proc Natl Acad Sci USA,1993,90:492-496.
共引文献9
-
1李泽孟,张劲,朱建宏,魏荣,蒋文英,刘建荣,张贺秋,张小平,任昭,王归真,杨璐.慢性丙型肝炎患者HCV不同基因片段抗体应答与脂代谢关系[J].陕西医学杂志,2008,37(7):820-822. 被引量:1
-
2陈银成,陈灼怀,关弘,徐洪.甲状腺髓样癌的诊断与鉴别诊断[J].诊断病理学杂志,2005,12(5):345-347. 被引量:5
-
3李建军,周愈琳,杨尤平.家族性甲状腺髓样癌的遗传与临床研究[J].中华肿瘤防治杂志,2007,14(24):1851-1853. 被引量:2
-
4陈砚凝,梁冰锋,刘爽,杨慧钗,王小玲.胃肠道间质瘤中Cx43、FLT3和RET的表达与临床病理特征及其预后的关系[J].现代中西医结合杂志,2008,17(30):4669-4671.
-
5陈健,赵海鸥.甲状腺髓样癌临床病理学特征[J].基层医学论坛,2008,12(31):994-995. 被引量:1
-
6卢国庆.甲状腺髓样癌的临床病理分析及诊断[J].甘肃医药,2009,28(4):287-288. 被引量:2
-
7权春姬.细针穿刺诊断甲状腺髓样癌一例[J].实用医技杂志,2011,18(9):915-915.
-
8高福平,魏谨,马平.有完整包膜的甲状腺髓样癌临床病理特征[J].现代肿瘤医学,2012,20(1):55-56. 被引量:2
-
9陈瑞慧,刘勤江,廖世奇.甲状腺髓样癌的研究进展[J].甘肃医药,2012,31(5):355-359. 被引量:10
同被引文献38
-
1张金双,李雪,吴筱辉,王珊珊,黄友梅,李萌,周君,苏冬明.2A型多发性内分泌腺瘤病超声表现[J].中华医学超声杂志(电子版),2013,10(3):231-233. 被引量:5
-
2周瑜琳,宁光.多发性内分泌腺瘤2A型[J].中国实用内科杂志:临床前沿版,2006,26(11):1831-1832. 被引量:10
-
3周瑜琳,朱绍兴,李建军,刘静波,殷民,肖步云,虞朝黎,王立明,顾丽群,崔斌,宁光,李小英,赵咏桔.15个多发性内分泌腺瘤2A型家系的临床和RET基因突变研究[J].中华内科杂志,2007,46(6):466-470. 被引量:11
-
4Decker RA,Peacock ML,Watson P.Hirschsprung disease in MEN-2A:increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation[J].Hum Mol Genet,1998,7(1):129-134
-
5Machens A,Niccoli-Sire P,Hoegel J,et al.Early malignant progression of hereditary medullary thyroid cancer[J].N Engl J Med,2003,349(16):1517-1525.
-
6Easton DF,Ponder MA,Cummings T,et al.The clinical and screening age-at-onset distribution for the MEN-2 syndrome[J].Am J Hum Genet,1989,44(2):208-215.
-
7Lee MJ,Hahn PF,Papanicolaou N,et al.Benign and malignant adrenal masses:CT distinction with attenuation coefficients,size,and observer analysis[J].Radiology,1991,179(2):415-418.
-
8Lombardo F,Baudin E,Chiefari E,et al.Familial medullary thyroid carcinoma:clinical variability and low aggressiveness associated with RET mutation at codon 804[J].J Clin Endocrinol Metab,2002,87(4):1674-1680.
-
9Kouvaraki MA,Shapiro SE,Perrier ND,et al.RET proto-oncogene:a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors[J].Thyroid,2005,15(6):531-544.
-
10于洋,高明,冯影,郑向前.甲状腺髓样癌外科处理与基因筛查原则探讨[J].中国肿瘤临床,2007,34(21):1226-1228. 被引量:5
引证文献5
-
1张金双,李雪,吴筱辉,王珊珊,黄友梅,李萌,周君,苏冬明.2A型多发性内分泌腺瘤病超声表现[J].中华医学超声杂志(电子版),2013,10(3):231-233. 被引量:5
-
2彭杰,张辉,李黎明,强万明.2A型多发性内分泌腺瘤10例临床分析[J].中国肿瘤临床,2009,36(10):551-553. 被引量:3
-
3朱辉.2A型多发性内分泌腺瘤临床特点分析[J].中外医疗,2012,31(10):58-58.
-
4罗鹏,刘丹,闫伟,陈山,刘跃新.多发性内分泌腺瘤病2A型中嗜铬细胞瘤的诊治[J].中国现代医生,2015,53(22):89-91.
-
5廖建,任正举,杨博,鲁栋梁,刘圣琢,杨璐辰,董强.多发性内分泌腺瘤病2A型2例报告[J].现代泌尿外科杂志,2018,23(6):483-484.
二级引证文献7
-
1金俊超,孙毅,李丙立,李平,张恒超,李鹏.探讨甲状腺锥体叶腺瘤伴囊性病变的诊断及治疗[J].中国实用医药,2014,9(2):132-133.
-
2于若飞,吴自勍,李爱民,金国萍,罗荣城.多发性内分泌腺瘤病2A型一例报道及文献回顾[J].南方医科大学学报,2014,34(6):909-912. 被引量:2
-
3武玉海,汤坤龙,李黎明,林毅.腹腔镜手术治疗多发性内分泌肿瘤ⅡA型嗜铬细胞瘤的效果观察[J].山东医药,2014,54(45):57-59.
-
4罗鹏,刘丹,闫伟,陈山,刘跃新.多发性内分泌腺瘤病2A型中嗜铬细胞瘤的诊治[J].中国现代医生,2015,53(22):89-91.
-
5单鸿,吴雁翔.切除手术治疗2A型多发性内分泌腺瘤的临床效果观察[J].当代医学,2016,22(9):34-35.
-
6吴年玮,金涛,韦堂墙,杨童欣,罗德毅,周亮,王坤杰,朱育春.腹腔镜肾上腺切除术在多发性内分泌肿瘤综合征-2A型中的应用[J].临床泌尿外科杂志,2016,31(8):690-692.
-
7王彦,杨梦凡,辛燕璐,孙晓芳,王颜刚,赵世华.以双侧肾上腺嗜铬细胞瘤反复发作为主要表现的MEN2A 1例诊治并文献复习[J].精准医学杂志,2019,34(1):45-47.
-
1张奇兵.甲状腺肿瘤的临床诊疗体会[J].中外医疗,2012,31(3):91-91. 被引量:4
-
2池正忠.甲状腺滤泡状腺癌31例治疗体会[J].外科理论与实践,2006,11(4):346-347.
-
3崔刚,朱清如.甲状腺滤泡状腺癌的病理研究[J].农垦医学,1995,0(4):228-229.
-
4普通外科——甲状腺、甲状旁腺[J].中国医学文摘(外科学),2008,27(5):392-393.
-
5张琰君.甲状腺滤泡状腺癌胸壁转移1例[J].陕西医学杂志,2004,33(3):286-287.
-
6闫国珍,刘扬,袁彦芬,李爱华.58例甲状腺滤泡状腺癌彩色超声及造影检查特征分析[J].包头医学院学报,2016,32(3):22-24. 被引量:4
-
7董云.甲状腺滤泡状腺癌和髓样癌的彩超表现及病理分析[J].中国医药科学,2013,3(22):109-111. 被引量:2
-
8颈、甲状腺[J].中国医学文摘(肿瘤学),2007,21(1):7-8.
-
9侯宝生,林擎天,金立,邓磊.手术治疗甲状腺癌32例[J].河北医学,2010,16(8):956-958. 被引量:2
-
10孙莉,侯海霞,余惠芳.用不同的放射剂量对甲状腺癌术后的残余癌进行放疗的效果观察[J].当代医药论丛,2015,13(16):198-199. 被引量:1